Latest Breaking News On - Research commercialisation - Page 2 : vimarsana.com

SYDNEY, June 22, 2023 /PRNewswire/ Australia's newest biotech incubator is calling for innovative early-stage Australian biotechs to take up residency in its much-awaited Melbourne-based facility. The "Jumar Bioincubator" will be supported by cash and in-kind contributions of approximately $45 million over ten years from its founding partners, global biotech leaderCSL,WEHI, andThe University of Melbourne, as well as an initial investment of $25 million fromBreakthrough Victoria. The incubator will connect early-stage and scaling biotech ventures with state-of-the-art facilities, infrastructure, and support needed to progress discoveries towards real-world treatments, while enhancing the opportunity to commercialise medical research. This will help to support research translation - the process of moving innovative medical discoveries through the research pipeline to become new products - for businesses in areas such as pharmaceuticals, diagnostics, medical devices, digit

New south walesSally ann williamsJim mccluskeyAndrew nashJumar bioincubatorUniversity of melbourneHead of researchMelbourne biomedical precinctGlobal headquartersAnn williamsCicada innovationsChief scientific officerDeputy vice chancellorMelbourne medical precinctBreakthrough victoriaJune 22